Summary
IDEXX Laboratories, Inc. (IDXX) reported strong financial performance for the year ended December 31, 2025, with total revenue reaching $4.30 billion, a 10.4% increase year-over-year. The Companion Animal Group (CAG) remains the primary revenue driver, contributing $3.95 billion, up 10.6% driven by strong recurring revenue from consumables and reference laboratory services. The company is strategically investing in Artificial Intelligence (AI) to enhance its diagnostic products and services, aiming to provide veterinarians with advanced tools for pet healthcare. Operational efficiency and strategic pricing contributed to a 11.8% increase in gross profit, with the gross profit margin improving to 61.8%. Despite inflationary pressures affecting product and labor costs, IDEXX demonstrated effective cost management, leading to a 20.5% increase in income from operations to $1.36 billion. The company also continued its share repurchase program, reflecting its commitment to returning value to shareholders. Looking ahead, IDEXX anticipates continued growth, though it acknowledges potential headwinds from macroeconomic factors and supply chain challenges, which it plans to manage through proactive strategies.
Financial Highlights
53 data points| Revenue | $4.30B |
| Cost of Revenue | $1.64B |
| Gross Profit | $2.66B |
| R&D Expenses | $251.21M |
| Operating Expenses | $1.30B |
| Operating Income | $1.36B |
| Net Income | $1.06B |
| EPS (Basic) | $13.17 |
| EPS (Diluted) | $13.08 |
| Shares Outstanding (Basic) | 80.43M |
| Shares Outstanding (Diluted) | 81.03M |
Key Highlights
- 1Total revenue increased by 10.4% to $4.30 billion for the year ended December 31, 2025.
- 2The Companion Animal Group (CAG) saw a 10.6% revenue increase, reaching $3.95 billion, driven by recurring revenue streams.
- 3Gross profit rose by 11.8% to $2.66 billion, with the gross profit margin improving to 61.8%.
- 4Income from operations grew by 20.5% to $1.36 billion.
- 5The company continues to invest in Artificial Intelligence (AI) integration across its product and service offerings.
- 6IDEXX repurchased approximately 2.4 million shares of its common stock during the year.
- 7International revenue showed robust growth at 13.7%, indicating expanding global reach.